A colleague of mine (Barbara Waszczak) is consulting for Sigma, and helping them to identify new research tools that they might be able to sell. She learned today about two drugs that might be useful for modulating entry into the dauer stage. They are
delta4-dafachronic acid and delta7-dafachronic acid. Are people interested in buying these compounds from Sigma?
Barbara asked me because I am the local “worm person”.
If you are interested in these compounds, or have any insights to share please email Barbara (at b.waszczak@neu.edu) or me (e.cram@neu.edu).
The references that describe these compounds are:
www.pnas.org/cgi/doi/10.1073/pnas.0904064106
Current Biology 19, 67–71, January 13, 2009
and
Mol Endocrinol, May 2009, 23(5):640–648